+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ophthalmic Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797835
The global ophthalmic devices market size attained a value of USD 50.7 billion in 2022. The market is further expected to grow at a CAGR of 4.5% during the forecast period of 2023-2031, likely to attain a value of USD 75.6 billion by 2031.

Ophthalmic Devices Market: Introduction

Ophthalmic devices are specialized medical instruments and equipment designed for the diagnosis, treatment, and management of various eye-related disorders and conditions. The field of ophthalmology has seen significant advancements in recent years, with the development of innovative devices and technologies that have improved patient care and outcomes. These devices play a crucial role in addressing a wide range of eye conditions, from common refractive errors to more complex issues, such as glaucoma and age-related macular degeneration.

Uses of Ophthalmic Devices:
Ophthalmic devices are employed in various aspects of eye care, including diagnosis, monitoring, surgical intervention, and vision correction. Some common uses of these devices are:
  • Diagnostic devices: Devices such as ophthalmoscopes, slit lamps, and optical coherence tomography (OCT) machines help healthcare professionals assess the internal structures of the eye, identify abnormalities, and diagnose various eye conditions
  • Monitoring devices: Tonometry devices, for example, are used to measure intraocular pressure, which is essential in monitoring the progression of glaucoma and evaluating the effectiveness of treatment
  • Surgical devices: Ophthalmic surgical devices, such as phacoemulsification machines, vitrectomy machines, and microkeratomes, facilitate various eye surgeries, including cataract removal, vitreoretinal procedures, and refractive surgery
  • Vision correction devices: Devices like contact lenses, eyeglasses, and intraocular lenses (IOLs) help correct refractive errors, such as myopia, hyperopia, and astigmatism, allowing individuals to see more clearly
  • Assistive devices: Low vision aids, such as magnifiers, telescopes, and electronic visual enhancement systems, can help individuals with vision impairments to maximize their remaining vision and improve their quality of life
Benefits of Ophthalmic Devices
The use of ophthalmic devices offers numerous benefits, including:
  • Accurate diagnosis: Advanced diagnostic devices enable healthcare professionals to accurately identify and diagnose a wide range of eye conditions, allowing for timely and appropriate treatment
  • Minimally invasive procedures: Many ophthalmic surgical devices enable minimally invasive procedures that reduce patient discomfort, recovery time, and the risk of complications
  • Improved outcomes: The use of advanced ophthalmic devices in surgical procedures has led to better patient outcomes, with higher success rates, improved vision, and a reduced risk of complications
  • Customized vision correction: Modern vision correction devices, such as contact lenses and IOLs, can be tailored to the specific needs of individual patients, providing personalized and effective vision correction solutions
  • Enhanced quality of life: Ophthalmic devices, particularly assistive devices for individuals with low vision, can significantly improve the quality of life for those affected by vision loss, enabling them to maintain their independence and engage in daily activities more easily
In conclusion, ophthalmic devices play a vital role in the diagnosis, treatment, and management of various eye conditions. They offer numerous benefits, including accurate diagnosis, minimally invasive procedures, improved patient outcomes, and enhanced quality of life. The continued development and innovation in ophthalmic devices will likely lead to even better patient care and outcomes in the future.

Ophthalmic Devices Market Segmentations

The market can be categorised into product type, application, end user, and region.

Market Breakup by Product Type

  • Optical Coherence Tomography Scanners
  • Fundus Cameras
  • Perimeters/Visual Field Analyzers
  • Autorefractors and Keratometres
  • Ophthalmic Ultrasound Imaging Systems
  • Ophthalmic A-Scan Ultrasound
  • Ophthalmic B-Scan Ultrasound
  • Ophthalmic Ultrasound Biomicroscopes
  • Ophthalmic Pachymeters
  • Tonometres
  • Slit Lamps
  • Phoropters
  • Wavefront Aberrometers
  • Optical Biometry Systems
  • Ophthalmoscopes
  • Lensometers
  • Corneal Topography Systems
  • Specular Microscopes
  • Retinoscopes

Market Breakup by Applications

  • Cataract
  • Vitreo retinal disorders
  • Glaucoma
  • Refractor Disorders
  • Cystic Fibrosis (CF)
  • Maple Syrup Urine Disease
  • Others

Market Breakup by End User

  • Clinical Laboratory
  • Hospitals
  • Eye Diagnostic Centres
  • Academic and Research Centres
  • Others

Ophthalmic Devices Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Ophthalmic Devices Market Scenario

The ophthalmic devices market has been witnessing significant growth in recent years due to several factors, including the rising prevalence of eye disorders, advancements in technology, and an increasing global aging population. This expanding market covers a wide range of devices, such as diagnostic, surgical, and vision correction instruments, catering to various aspects of eye care.

One of the primary drivers of the ophthalmic devices market is the increasing prevalence of eye disorders worldwide. Conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy have become more common, particularly among the aging population. As life expectancy increases globally, the demand for ophthalmic devices to diagnose, treat, and manage these age-related eye disorders is expected to rise significantly.

Technological advancements have also played a crucial role in the growth of the ophthalmic devices market. Innovations in diagnostic instruments, such as optical coherence tomography (OCT), have enabled healthcare professionals to diagnose eye conditions more accurately and at earlier stages. Similarly, the development of advanced surgical devices and techniques, including femtosecond lasers and minimally invasive glaucoma surgery (MIGS), has improved patient outcomes and expanded treatment options for various eye conditions.

Another factor contributing to market growth is the increasing demand for vision correction devices. The growing global prevalence of refractive errors, such as myopia and astigmatism, has led to a higher demand for eyeglasses, contact lenses, and intraocular lenses (IOLs). Furthermore, the popularity of laser-assisted in situ keratomileusis (LASIK) and other refractive surgeries has bolstered the market for ophthalmic surgical devices.

Despite the overall growth, the ophthalmic devices market faces some challenges. The high cost of certain advanced devices and surgical procedures may limit their accessibility, particularly in low- and middle-income countries where healthcare resources may be limited. Additionally, the stringent regulatory landscape for medical devices can slow down the approval and adoption of new technologies.

Looking ahead, the ophthalmic devices market is expected to continue its growth trajectory due to the increasing prevalence of eye disorders, an aging global population, and ongoing technological advancements. To ensure equitable access to these vital devices, efforts should be made to address cost and accessibility barriers, especially in resource-limited settings. The continued development and innovation in ophthalmic devices will likely lead to better patient care and outcomes in the years to come.

Key Players in the Global Ophthalmic Devices Market

The report gives an in-depth analysis of the key players involved in the ophthalmic devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Essilor Luxottica
  • Alcon Management S. A
  • Johnson & Johnson Vision
  • HOYA Corporation
  • Bausch + Lomb
  • Zeiss
  • Neo Vision Foundation
  • Lumenis Be Ltd
  • ClearLab
  • OPHTEC BV
  • HEINE Optotechnik GmbH & Co. KG
  • Topcon
  • Glaukos Corporation
  • Haag-Streit Group
  • NIDEK Co. Ltd
  • STAAR Surgical
  • Ziemer Ophthalmic Systems
  • Oculentis
  • Heidelberg Engineering GmbH
  • Canon India Pvt Ltd.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ophthalmic Devices Market Overview
3.1 Global Ophthalmic Devices Market Historical Value (2016-2022)
3.2 Global Ophthalmic Devices Market Forecast Value (2023-2031)
4 Global Ophthalmic Devices Market Landscape
4.1 Global Ophthalmic Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ophthalmic Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Ophthalmic Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ophthalmic Devices Market Segmentation
6.1 Global Ophthalmic Devices Market by Product Type
6.1.0 Ophthalmic Surgical Devices
6.1.0.0 Refractive Error Surgical Devices
6.1.0.1 Glaucoma Surgical Devices
6.1.0.2 Cataract Surgery Devices
6.1.0.3 Vitreoretinal Surgical Devices
6.1.1 Ophthalmic Diagnostic and Monitoring Devices
6.1.1.0 Refractors
6.1.1.1 Corneal Topography Systems
6.1.1.2 Retinal Ultrasound Systems
6.1.1.3 Fundus Camera
6.1.1.4 Ophthalmoscopes
6.1.1.5 Optical Coherence Tomography Systems
6.1.1.6 Perimeters
6.1.1.7 Slit Lamps
6.1.1.8 Tonometer
6.1.2 Ophthalmic Vision Care Devices
6.1.2.0 Contact Lenses
6.1.2.1 Spectacle Lenses
6.2 Global Ophthalmic Devices Market by Applications
6.2.0 Market Overview
6.2.1 Cataract
6.2.2 Vitreo retinal disorders
6.2.3 Glaucoma
6.2.4 Refractor Disorders
6.2.5 Others
6.3 Global Ophthalmic Devices Market by End User
6.3.0 Market Overview
6.3.1 Hospitals and Eye Clinics
6.3.2 Academic and Research Centres
6.3.3 Others
6.4 Global Ophthalmic Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Ophthalmic Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ophthalmic Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ophthalmic Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ophthalmic Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ophthalmic Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Essilor International
17.1.0 Financial Analysis
17.1.1 Product Portfolio
17.1.2 Demographic Reach and Achievements
17.1.3 Mergers and Acquisitions
17.1.4 Certifications
17.2 Alcon Inc.
17.2.0 Financial Analysis
17.2.1 Product Portfolio
17.2.2 Demographic Reach and Achievements
17.2.3 Mergers and Acquisitions
17.2.4 Certifications
17.3 Johnson & Johnson
17.3.0 Financial Analysis
17.3.1 Product Portfolio
17.3.2 Demographic Reach and Achievements
17.3.3 Mergers and Acquisitions
17.3.4 Certifications
17.4 HOYA Corporation
17.4.0 Financial Analysis
17.4.1 Product Portfolio
17.4.2 Demographic Reach and Achievements
17.4.3 Mergers and Acquisitions
17.4.4 Certifications
17.5 Bausch & Lomb Incorporated
17.5.0 Financial Analysis
17.5.1 Product Portfolio
17.5.2 Demographic Reach and Achievements
17.5.3 Mergers and Acquisitions
17.5.4 Certifications
17.6 Carl Zeiss Meditec AG
17.6.0 Financial Analysis
17.6.1 Product Portfolio
17.6.2 Demographic Reach and Achievements
17.6.3 Mergers and Acquisitions
17.6.4 Certifications
17.7 Neo Vision Foundation
17.7.0 Financial Analysis
17.7.1 Product Portfolio
17.7.2 Demographic Reach and Achievements
17.7.3 Mergers and Acquisitions
17.7.4 Certifications
17.8 Lumenis BE Ltd.
17.8.0 Financial Analysis
17.8.1 Product Portfolio
17.8.2 Demographic Reach and Achievements
17.8.3 Mergers and Acquisitions
17.8.4 Certifications
17.9 ClearLab
17.9.0 Financial Analysis
17.9.1 Product Portfolio
17.9.2 Demographic Reach and Achievements
17.9.3 Mergers and Acquisitions
17.9.4 Certifications
17.10 OPHTEC BV
17.10.0 Financial Analysis
17.10.1 Product Portfolio
17.10.2 Demographic Reach and Achievements
17.10.3 Mergers and Acquisitions
17.10.4 Certifications
17.11 HEINE Optotechnik GmbH & Co. KG
17.11.0 Financial Analysis
17.11.1 Product Portfolio
17.11.2 Demographic Reach and Achievements
17.11.3 Mergers and Acquisitions
17.11.4 Certifications
17.12 Topcon Corporation
17.12.0 Financial Analysis
17.12.1 Product Portfolio
17.12.2 Demographic Reach and Achievements
17.12.3 Mergers and Acquisitions
17.12.4 Certifications
17.13 Glaukos Corporation
17.13.0 Financial Analysis
17.13.1 Product Portfolio
17.13.2 Demographic Reach and Achievements
17.13.3 Mergers and Acquisitions
17.13.4 Certifications
17.14 Haag-Streit Group
17.14.0 Financial Analysis
17.14.1 Product Portfolio
17.14.2 Demographic Reach and Achievements
17.14.3 Mergers and Acquisitions
17.14.4 Certifications
17.15 NIDEK Co. Ltd.
17.15.0 Financial Analysis
17.15.1 Product Portfolio
17.15.2 Demographic Reach and Achievements
17.15.3 Mergers and Acquisitions
17.15.4 Certifications
17.16 STAAR Surgical
17.16.0 Financial Analysis
17.16.1 Product Portfolio
17.16.2 Demographic Reach and Achievements
17.16.3 Mergers and Acquisitions
17.16.4 Certifications
17.17 Ziemer Ophthalmic Systems AG
17.17.0 Financial Analysis
17.17.1 Product Portfolio
17.17.2 Demographic Reach and Achievements
17.17.3 Mergers and Acquisitions
17.17.4 Certifications
17.18 Heidelberg Engineering GmbH
17.18.0 Financial Analysis
17.18.1 Product Portfolio
17.18.2 Demographic Reach and Achievements
17.18.3 Mergers and Acquisitions
17.18.4 Certifications
17.19 Canon
17.19.0 Financial Analysis
17.19.1 Product Portfolio
17.19.2 Demographic Reach and Achievements
17.19.3 Mergers and Acquisitions
17.19.4 Certifications
18 Global Ophthalmic Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Essilor International
  • Alcon Inc.
  • Johnson & Johnson
  • Hoya Corporation
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Neo Vision Foundation
  • Lumenis Be Ltd.
  • Clearlab
  • Ophtec Bv
  • Heine Optotechnik GmbH & Co. Kg
  • Topcon Corporation
  • Glaukos Corporation
  • Haag-Streit Group
  • Nidek Co. Ltd.
  • Staar Surgical
  • Ziemer Ophthalmic Systems AG
  • Heidelberg Engineering GmbH
  • Canon

Methodology

Loading
LOADING...

Table Information